In addition, IMiDs also directly affect myeloma cell survival by binding to Cereblon (CRBN) – a component of the CRL4CRBN E3 ubiquitin ligase complex (CUL4–ROC1–DDB1–CRBN). The gene discussed is CRBN; the disease is plasma cell myeloma.